Fernando Antoñanzas
Impact in
- Economics and Econometrics top 1%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Healthcare Policy and Management
Papers in
-
- Antibiotic Use and Resistance 8
-
- Health Systems, Economic Evaluations, Quality of Life 56
- Pharmaceutical Economics and Policy 31
- Healthcare Policy and Management 23
- Co-authors
- Juan OlivaJavier MarAnna García‐AltésJoan RoviraRamón GisbertJaume Puig‐JunoyRoberto Rodríguez‐IbeasLucinda L. Baker
- Journals
- PharmacoEconomics (14 papers)Value in Health (12 papers)The European Journal of Health Economics (7 papers)Antibiotics (3 papers)Journal of Risk and Uncertainty (2 papers)
- Partner nations
- SpainUnited StatesNetherlands
In The Last Decade
Fernando Antoñanzas
137 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 156
- Economics and Econometrics 768
- Applied Microbiology and Biotechnology 49
- Family Practice 49
- Rehabilitation 137
- Endocrinology, Diabetes and Metabolism 264
Countries citing papers authored by Fernando Antoñanzas
This map shows the geographic impact of Fernando Antoñanzas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Antoñanzas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Antoñanzas more than expected).
Fields of papers citing papers by Fernando Antoñanzas
This network shows the impact of papers produced by Fernando Antoñanzas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Antoñanzas. The network helps show where Fernando Antoñanzas may publish in the future.
Co-authors
The 25 scholars most cited alongside Fernando Antoñanzas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 5 | |
| 4 | 2021 | 5 | |
| 5 | 2021 | 6 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 12 | |
| 8 | 2020 | 2 | |
| 9 | 2020 | 2 | |
| 10 | 2017 | 2 | |
| 11 | La vacunación anti-neumocócica con la vacuna conjugada 13-valente en población inmunocompetente de 65 años: Analisis del impacto presupuestario en españa aplicando un modelo de transmisión dinámica | 2016 | 2 |
| 12 | [A Dynamic Model to Estimate the Budget Impact of a Pneumococcal Vaccination Program in a 65 Year-old immunocompetent Spanish Cohort with 13-Valent Pneumococcal Conjugate Vaccine]. | 2016 | 3 |
| 13 | 2015 | 1 | |
| 14 | 2014 | 11 | |
| 15 | 2014 | 13 | |
| 16 | 2013 | 4 | |
| 17 | 2011 | 1 | |
| 18 | PROVISION OF HEALTH CARE SERVICES IN CANADA: CHALLENGES AND OPPORTUNITIES | 2009 | 0 |
| 19 | Una propuesta de guía pra la evaluación económica aplicada a las tecnologías sanitarias. ¿Ha llegado el momento? | 2008 | 3 |
| 20 | 2008 | 35 |
About Fernando Antoñanzas
Fernando Antoñanzas is a scholar working on Applied Microbiology and Biotechnology, Economics and Econometrics, Family Practice, General Health Professions and Health, having authored 140 papers that have together received 2.3k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (56 papers), Pharmaceutical Economics and Policy (31 papers), Healthcare Policy and Management (23 papers), Healthcare cost, quality, practices (17 papers), Global Health Care Issues (10 papers), Smoking Behavior and Cessation (8 papers), Antibiotic Use and Resistance (8 papers) and Chronic Disease Management Strategies (7 papers). The work is most often cited by research in Economics and Econometrics (768 citations), Applied Microbiology and Biotechnology (49 citations), Family Practice (49 citations), Rehabilitation (137 citations) and Endocrinology, Diabetes and Metabolism (264 citations). Fernando Antoñanzas has collaborated with scholars based in Spain, United States and Netherlands. Frequent co-authors include Juan Oliva, Javier Mar, Anna García‐Altés, Joan Rovira, Ramón Gisbert, Jaume Puig‐Junoy, Roberto Rodríguez‐Ibeas, Lucinda L. Baker, Sharon K. DeMuth and Richard Chambers. Their work appears in journals such as PharmacoEconomics, Value in Health, The European Journal of Health Economics, Antibiotics and Journal of Risk and Uncertainty.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.